Ultragenyx Pharmaceutical Inc. Real Estate Contracts & Agreements
18 Contracts & Agreements
- Lease Agreements (18 contracts)
- Second Amendment, dated October 21, 2020, to the Lease Agreement dated December 15, 2019 between Ultragenyx Pharmaceutical Inc. and ARE-San Francisco No. 17, LLC (Filed With SEC on February 12, 2021)
- First Amendment, dated September 20, 2020, to the Lease Agreement dated December 15, 2019 between Ultragenyx Pharmaceutical Inc. and ARE-San Francisco No. 17, LLC (Filed With SEC on February 12, 2021)
- Lease Agreement, dated December 15, 2019, between Ultragenyx Pharmaceutical Inc. and ARE-San Francisco No. 17, LLC (Filed With SEC on February 12, 2021)
- Fourth Amended and Restated Amendment to Lease Agreement between Ultragenyx Pharmaceutical Inc. and ARE-MA Region No. 20, LLC (Filed With SEC on October 27, 2020)
- Fourth Amendment, dated as of March 31, 2020, to the Lease Agreement dated as of October 30, 2015 by and between Ultragenyx Pharmaceutical Inc. and ARE-MA Region No., LLC (Filed With SEC on July 31, 2020)
- Third Amendment, dated as of July 29, 2019, to the Lease Agreement dated as of October 30, 2015 by and between Ultragenyx Pharmaceutical Inc. and ARE-MA Region No., LLC (Filed With SEC on July 31, 2020)
- Commercial Lease, dated July 2, 2018, between Ultragenyx Pharmaceutical Inc. and 32 Leveroni LLC (Filed With SEC on February 14, 2020)
- Office Lease, dated April 19, 2019, between Ultragenyx Pharmaceutical Inc. and Woburn MCB II, LLC (Filed With SEC on February 14, 2020)
- Addendum #6 to Standard Lease, effective as of April 29, 2019, by and between Ultragenyx Pharmaceutical Inc. and Condiotti Enterprises, Inc (Filed With SEC on August 2, 2019)
- Third Lease Amendment to the Lease between Ultragenyx Pharmaceutical Inc. and Rivertech Associates II, LLC, effective December 31, 2018 (Filed With SEC on February 20, 2019)
- Second Amendment to Lease Agreement, made July 1, 2018, between Ultragenyx Pharmaceutical Inc. and ARE-MA Region No. 20, LLC (Filed With SEC on August 3, 2018)
- Addendum 4 to Standard Lease, effective April 1, 2018, between Ultragenyx Pharmaceutical Inc. and Condiotti Enterprises, Inc (Filed With SEC on August 3, 2018)
- First Amendment to Lease Agreement, dated March 20, 2018, between ARE-MA Region No. 20, LLC and Ultragenyx Pharmaceutical Inc (Filed With SEC on May 8, 2018)
- LEASE AGREEMENT BETWEEN MARINA BOULEVARD PROPERTY, LLC, AS LANDLORD, AND ULTRAGENYX PHARMACEUTICAL INC., AS TENANT DATED December 8, 2015 TABLE OF CONTENTS (Filed With SEC on February 26, 2016)
- Addendum #5 To The Lease Dated on or about July 1, 2011 By and Between Condiotti Enterprises, Inc. (Lessor) And Ultragenyx Pharmaceutical Inc. (Lessee) (Filed With SEC on February 26, 2016)
- Addendum #4 To The Lease Dated on or about July 1, 2011 By and Between Condiotti Enterprises, Inc. (Lessor) And Ultragenyx Pharmaceutical Inc. (Lessee) (Filed With SEC on March 13, 2015)
- Addendum #3 To The Lease By and Between Condiotti Enterprises, Inc. (Lessor) And Ultragenyx Pharmaceutical,Inc. (Lessee) Dated on or about July 1, 2011 (Filed With SEC on February 25, 2014)
- LAKEPOINT BUSINESS PARK STANDARD LEASE BASICLEASE INFORMATION (Filed With SEC on November 8, 2013)
